RT Book, Section
A1 Wilson, James M.
A1 Willerson, James T.
A2 Cohn, Lawrence H.
A2 Adams, David H.
SR Print(0)
ID 1144151828
T1 Myocardial Revascularization with Percutaneous Devices
T2 Cardiac Surgery in the Adult, 5e
YR 2017
FD 2017
PB McGraw-Hill Education
PP New York, NY
SN 9780071844871
LK accesscardiology.mhmedical.com/content.aspx?aid=1144151828
RD 2023/06/09
AB At  its  height,  the  success  of  surgical  coronary  revascularization  spurred  improvement  in  catheter-based  technology—first  for  imaging  quality,  and  later  for  attempted  therapy.  In  1974,  Andreas  Gruentzig  completed  the  development  of  a  double-lumen  balloon  catheter  that  was  miniaturized  for  use  in  coronary  arteries.  Soon  afterward,  techniques  for  percutaneous  transluminal  coronary  angioplasty  (PTCA)  expanded  as  technical  breakthroughs  were  applied  to  subselective  catheters,  devices,  guidewires,  balloon  materials,  coronary  stents,  and  circulatory  support.  Currently,  trial  evidence  attests  that  percutaneous  therapy  is  useful  as  a  treatment  in  patients  with  poorly  controlled  angina  whose  anatomy  does  not  imply  a  survival  benefit  from  revascularization,  and  for  emergency  revascularization  during  ST-segment  elevation  myocardial  infarction  (MI).  Surgical  and  percutaneous  revascularization,  however,  cannot  be  considered  equivalent.1